Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $255000.0.

  • Health Catalyst's Capital Expenditures fell 6382.98% to $255000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 2400.55%. This contributed to the annual value of $1.6 million for FY2024, which is 3074.43% up from last year.
  • Latest data reveals that Health Catalyst reported Capital Expenditures of $255000.0 as of Q3 2025, which was down 6382.98% from -$230000.0 recorded in Q2 2025.
  • Health Catalyst's 5-year Capital Expenditures high stood at $5.9 million for Q1 2021, and its period low was -$230000.0 during Q2 2025.
  • Its 5-year average for Capital Expenditures is $850736.8, with a median of $413000.0 in 2024.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 127429.91% in 2021, then crashed by 17931.03% in 2025.
  • Quarter analysis of 5 years shows Health Catalyst's Capital Expenditures stood at $623000.0 in 2021, then crashed by 33.39% to $415000.0 in 2022, then tumbled by 38.55% to $255000.0 in 2023, then surged by 61.96% to $413000.0 in 2024, then crashed by 38.26% to $255000.0 in 2025.
  • Its Capital Expenditures stands at $255000.0 for Q3 2025, versus -$230000.0 for Q2 2025 and $670000.0 for Q1 2025.